Comparing the Efficacy of Concurrent EGFR-TKI and Whole-Brain Radiotherapy vs EGFR-TKI Alone as a First-Line Therapy for Advanced EGFR-mutated Non-Small-Cell Lung Cancer With Brain Metastases: A Retrospective Cohort Study
Cancer Management and Research - New Zealand
doi 10.2147/cmar.s184922
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 1, 2019
Authors
Publisher
Informa UK Limited